Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 58 for “"lysosomal dysfunction"”.
-
Glycosphingolipid dysregulation and lysosomal dysfunction in motor neuron disease
… the early-onset rare neurodegenerative lysosomal storage disorders (LSDs) have been studied as discrete metabolic diseases in their own right. However, some links with common late-onset neurodegenerative diseases, including motor neurone disease (MND), have recently emerged. Reports show …
-
Lysosomal dysfunction and microglial hyperactivation in models of progranulin deficiency
… 2 (TREM2) deficiency and the connection between lysosomal deficiency and microglial hyperactivation. Microglia majorly contribute to the progression and pathology of neurodegenerative disorders like Alzheimer`s disease (AD) and frontotemporal lobal degeneration (FTLD) and additionally recent …
-
Lysosomal dysfunction and glycosphingolipid dysregulation in rare and common neurodegenerative diseases
… the rare early-onset neurodegenerative lysosomal storage disorders (LSDs) have been studied as discrete metabolic diseases in their own right. However, in recent years links with more common late-onset neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and …
-
The Stratification of Sporadic Parkinson’s Disease Patients by Cellular Mechanism.
… both mechanistically and clinically. Several dysfunctional mechanisms have been identified, including mitochondrial and lysosomal dysfunction. Disease-modifying therapeutics target specific mechanisms of disease to repair dysfunction. A key reason why neuroprotection trials have failed in PD …
-
LYSOSOME DYSFUNCTION IN NEURODEGENERATIVE DISEASES
Lysosomal dysfunction represents a major pathogenic bottleneck in neurodegenerative diseases. Lysosome not only functions as a simple terminal degradation chamber, but also as a dynamic regulatory center, coordinating the basic processes including autophagic turnover, endocytic processing, membrane …
-
TRPM2 Channel-Mediated Signalling Mechanisms for Neuronal Cell Death
… and Aβ42 induced intracellular Zn2+ increase, lysosomal dysfunction and Zn2+ release, mitochondrial Zn2+ accumulation, dysfunction and ROS generation. Bafilomycin A1-induced lysosomal dysfunction also resulted in mitochondrial Zn2+ accumulation and ROS generation. These events were abolished by …
-
AUTOFLURORESCENCE AS A BIOMARKER FOR SCHIZOPHRENIA AND BATTENS DISEASE: STRATIFICATION OF PATIENTS AND MOLECULAR CHARACTERISATION FOR TARGETED THERAPEUTIC INSIGHTS
Recent evidence implicates lysosomal dysfunction as a convergent mechanism across neurological and psychiatric disorders, including schizophrenia (SZ). In a prior study, we observed lysosomal abnormalities in SZ postmortem brains. To investigate further, we conducted two lines of preliminary …
-
Studying the Roles of Autophagy Protein ATG7 and Transcription Factor EB (TFEB) in Mouse Model of Krabbe Disease
… disease (KD) is a severe autosomal recessive lysosomal storage disorder (LSD) caused by mutations in the galactosylcerebrosidase (Galc) gene, leading to Galc deficiency and subsequent demyelination, neurodegeneration, and premature death. Despite existing clinical trials and therapies that can …
-
Novel mechanisms of autophagy-lysosome dysfunction in GBA1 Parkinson disease
… Mutations in the GBA1 gene, which encodes the lysosomal enzyme glucocerebrosidase (GCase), are the most common genetic risk factor for PD and drive disease progression through lysosomal dysfunction and impaired proteostasis. However, optimal strategies for restoring autophagy-lysosome function …
-
Mechanisms of DHA Neuroprotection from PA Induced Lipotoxieity
… lipotoxicity may be mediated downstream by lysosomal dysfunction. Accordingly, inhibition of lysosomal proteases in particular Cathepsin L led to decreased PA induced lipotoxicity and cell death. Importantly, DHA protection mechanism from FA induced lipotoxicity in neurons may be centered at …
-
Neuraminidases as potential therapeutic targets for Parkinson’s disease
… linked to multiple mechanisms, including lysosomal dysfunction and impaired cellular homeostasis. Notably, over 50 genes encoding lysosomal proteins impaired in rare lysosomal storage disorders (LSDs) have now been identified as PD risk factors. Altered GSL metabolism, linked to lysosomal …
-
The Role Of Mitochondrial And Lysosomal Damage In Neurotoxicity From Parkinson 'S-Related Environmental Exposures
… contaminants converge on mitochondrial and lysosomal dysfunction to activate parallel neurotoxic signaling pathways, with a focus on the LRRK2 kinase and the cGAS-STING innate immune pathway. Chapter 2 demonstrates that pharmacological inhibition of LRRK2 kinase activity protects against …
-
The therapeutic potential of lysosomal cathepsins D, B and L (CTSD, CTSB and CTSL) on alpha-synuclein pathology and Parkinson Disease
… by mitosis. It is therefore not surprising that lysosomal dysfunction underlies pathologies featuring protein aggregation, such as Neuronal Ceroid Lipofuscinosis (NCL) and Parkinson disease (PD). Given that several aggregation-prone proteins including alpha-synuclein (SNCA) are known substrates …
-
Mechanism of action of enzymes involved in rare glycogen storage diseases
… diseases, including neurodegeneration and lysosomal dysfunction. Glycogen synthesis is carried out by glycogenin (GN), glycogen synthase (GS) and glycogen branching enzyme (GBE). GN initiates glycogen synthesis through autoglucosylation to produce a primer glucose chain of 8-12 units. GS …
-
Endolysosomal Mechanisms of SARS-CoV-2 Spike-Induced Inflammatory Response And Senescence In Human Astrocytes
… S1 was also found to disrupt astrocytic lysosomal function, leading to increased lysosomal permeability and the release of enzymes like cathepsins B and D. This lysosomal dysfunction, evidenced by Galectin-3 puncta formation and altered morphology, suggests a mechanism by which S1-induced …
-
GBA1 and Parkinson’s Disease: Development of a Comprehensive Assay Framework and its Application in Clinical Samples
… Among several pathogenic pathways proposed, lysosomal dysfunction has emerged as a central disease mechanism, closely linked to genetic variants in the PD-associated genes LRRK2 and GBA1. GBA1 encodes a lysosomal enzyme glucocerebrosidase (GCase), which is critical for maintaining lysosomal …
-
Reduction of Sphingomyelinases Associated with Progranulin Deficiency and Frontotemporal Dementia
… involved in the regulation of numerous lysosomal enzymes. Here, we describe how loss of progranulin deficiency causes impairment of acid sphingomyelinase (aSMase) in Grn–/– mice and how FTLD with TDP type A, regardless of progranulin mutation, is associated with reduction of neutral …
-
The role of the deubiquitinase cyld in neuronal physiology and ageing
… In addition, we report perturbations of lysosomal morphology and acidification in cyld-1 mutant nematodes, indicative of lysosomal dysfunction. Our findings emphasize the pivotal role of lysine63 polyubiquitination as a master regulator of neuronal homeostasis and highlight CYLD and other …
-
Development of analytical tools to enrich and identify protein dopaminylation
… levels have been linked to mitochondrial and lysosomal dysfunction, oxidative stress, and increased expression of α-synuclein in dopaminergic neurons. Outside of vesicles, dopamine is rapidly oxidized and accumulates in cells as various polymerized forms including neuromelanin. Oxidized …
-
Endolysosomal dysfunction and exosome secretion: implications for neurodegenerative disorders
Defects in endolysosomal and autophagic functions are increasingly viewed as key pathological features of neurodegenerative disorders. A master regulator of these functions is phosphatidylinositol- 3-phosphate (PI3P), a phospholipid synthesized primarily by class III PI 3-kinase Vps34. Here we …
Page 1 of 3